Study Presented at the International Society for Heart and Lung Transplant 42nd Annual Meeting and Scientific Sessions 2022 Oak Ridge, TN, May 02, 2022 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces new data validating the […]
Tag: LVAD
CorWave Successfully Performed a 90-Day In Vivo Study on Its Revolutionary Cardiac Pump Synchronized With the Native Heart, Results Presented at ASAIO Meeting
PARIS–(BUSINESS WIRE)–CorWave, a French medical device company committed to the fight against heart failure, announced that it has successfully completed the first 90-day preclinical study to evaluate its left ventricular assist device (LVAD) operating synchronously with the native heart without […]
Corvion Receives Breakthrough Device Designation from FDA
WEBSTER, Texas, Dec. 16, 2020 /PRNewswire/ — Corvion – developer of fully implanted mechanical circulatory support devices – announced today that it has received Breakthrough Device Designation for its fully implanted Left Ventricular Assist Device (LVAD) from the FDA. The designation will […]
Sahyadri Hospitals Conducts First Successful Rare LVAD Procedure in Pune, an Alternative to Heart Transplant
City’s first successful Mechanical device implant on heart gives new lease of life to a Yemeni National PUNE, India, Feb. 17, 2020 /PRNewswire/ — Sahyadri Super Speciality Hospital, Deccan recently conducted a rare and high risk left ventricular assist device implantation (LVAD) […]
Medtronic Receives FDA “Breakthrough Device Designation” for Developing Fully Implantable Heart Pump
DUBLIN, Oct. 29, 2019 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for the Medtronic Fully Implantable Left Ventricular Assist Device […]
CorWave Presented First Successful In Vivo 60-Day Study on Its Innovative LVAD Cardiac Support Device
CLICHY, France–(BUSINESS WIRE)–CorWave announced that it successfully completed its first 60-day preclinical study to evaluate its Left Ventricular Assist Device (LVAD). The results were presented at the 46th Annual Conference of the European Society for Artificial Organs (ESAO) in Hannover. Trevor […]
CorWave to Report First Successful In Vivo Survival at 30-Day Milestone with Its Innovative LVAD Cardiac Support Device
CLICHY, France–(BUSINESS WIRE)–CorWave announced today that results from chronic preclinical studies to evaluate its Left Ventricular Assist Device (LVAD) will be presented at the 65th Annual Conference of the American Society for Artificial Internal Organs (ASAIO) in San Francisco. The […]
CMS Decision on TAVR Puts Patients at the End of the Line, says Heart Valve Voice
WASHINGTON, June 24, 2019 /PRNewswire/ — The Centers for Medicaid and Medicare Services last Friday issued their final National Coverage Decision on how hospitals will be approved to do the TAVR (transaortic valve replacement) procedure, a less invasive valve replacement treatment that avoids […]
Journal of Heart and Lung Transplantation releasing themed issue on MCS to coincide with ISHLT 2019
Orlando, Florida, April 03, 2019 (GLOBE NEWSWIRE) — The Journal of Heart and Lung Transplantation is releasing its themed issue on Mechanical Circulatory Support to coincide with the 39th Annual Meeting of the International Society for Heart and Lung Transplantation being held April […]
Memorandum of Understanding for Confirmatory Trial to Support Marketing Approval of Revascor for Reduction of Gastrointestinal Bleeding in LVAD Patients
NEW YORK and MELBOURNE, Australia, March 26, 2019 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, today announced that the International Center for Health Outcomes and Innovation Research (InCHOIR) at the Icahn School […]